Table 2.
Demographics, aetiology of NiP, treatments and outcomes.
| Normal EF | ED | |
|---|---|---|
| Number of patients | 16 | 9 |
| Age (median and IQR) *p = 0.3 Mann–Whitney U test | 21 (19.5–40) | 27 (22–36.5) |
| Aetiology | ||
| Fall astride | 16 | 8 |
| Iatrogenic | 0 | 1 |
| Number of AVFs: *p = 0.351 Binomial Logistic Regression | ||
| Unilateral AVF | 14 | 7 |
| Bilateral AVF | 2 | 2 |
| Duration of NiP/days from injury to treatment (median and IQR) *p = 0.18 Mann–Whitney U test | 28 (16.5–97) | 92 (27–121) |
| Number of Treatment(s): *p = 0.35 Binomial Logistic Regression | ||
| Conservative management | 3 | 0 |
| 1x embolization | 7 | 5 |
| 2x embolization | 4 | 3 |
| 3x embolization | 2 | 1 |
| Embolic type: *p = 0.114 Binomial Logistic Regression | ||
| Gelfoam | 1 | 2 |
| Thrombin | 4 | 0 |
| Thrombin/Gelfoam + Microcoils | 8 | 7 |
| IIEF-EF score at last clinical follow up (median and IQR) *p < 0.0002 Mann–Whitney U test | 29 (2) | 17 (8) |
AVF arteriovenous fistula, ED Erectile dysfunction, EF Erectile function, IIEF-EF International Index of Erectile Function-Erectile function score, IQR interquartile range.